Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease

被引:11
|
作者
Wu C. [1 ]
Liu X. [1 ]
Zhong L. [1 ]
Zhou Y. [1 ,2 ]
Long L. [3 ]
Yi T. [4 ]
Chen S. [1 ]
Li Y. [1 ]
Chen Y. [1 ]
Shen L. [1 ]
Zeng Q. [1 ]
Tang S. [1 ]
机构
[1] Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangdong, Guangzhou
[2] Department of Gastroenterology, The First Affiliated Hospital, Gannan Medical University, Ganzhou
[3] Department of Gastroenterology, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangdong, Guangzhou
[4] Department of Oncology, Affiliated Hospital of YouJiang Medical University for Nationalities, Guangxi, Baise
关键词
461.2 Biological Materials and Tissue Engineering - 461.6 Medicine and Pharmacology - 461.9 Biology - 804.1 Organic Compounds - 922.2 Mathematical Statistics;
D O I
10.1155/2023/9245667
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent hepatic pathology worldwide. However, the precise molecular mechanisms for NAFLD are still not sufficiently explained. Recently, a new mode of cell death (cuproptosis) is found. However, the relationship between NAFLD and cuproptosis remains unclear. We analyzed three public datasets (GSE89632, GSE130970, and GSE135251) to identify cuproptosis-related genes stably expressed in NAFLD. Then, we performed a series of bioinformatics analyses to explore the relationship between NAFLD and cuproptosis-related genes. Finally, 6 high-fat diet- (HFD-) induced NAFLD C57BL/6J mouse models were established to carry out transcriptome analysis. The results of gene set variation analysis (GSVA) revealed that the cuproptosis pathway was abnormally activated to a certain degree (p=0.035 in GSE89632, p=0.016 in GSE130970, p=0.22 in GSE135251), and the principal component analysis (PCA) of the cuproptosis-related genes showed that the NAFLD group separated from the control group, with the first two principal components accounting for 58.63%-74.88% of the variation. Among three datasets, two cuproptosis-related genes (DLD and PDHB, p<0.01 or 0.001) were stably upregulated in NAFLD. Additionally, both DLD (AUC=0.786-0.856) and PDHB (AUC=0.771-0.836) had favorable diagnostic properties, and the multivariate logistics regression model further improved the diagnostic properties (AUC=0.839-0.889). NADH, flavin adenine dinucleotide, and glycine targeted DLD, and pyruvic acid and NADH targeted PDHB in the DrugBank database. The DLD and PDHB were also associated with clinical pathology, especially with steatosis (DLD, p=0.0013-0.025; PDHB, p=0.002-0.0026) and NAFLD activity score (DLD, p=0.004-0.02; PDHB, p=0.003-0.031). What is more, DLD and PDHB were correlated with stromal score (DLD, R=0.38, p<0.001; PDHB, R=0.31, p<0.001) and immune score (DLD, R=0.26, p<0.001; PDHB, R=0.27, p<0.001) in NAFLD. Furthermore, Dld and Pdhb were also significantly upregulated in the NAFLD mouse model. In conclusion, cuproptosis pathways, especially DLD and PDHB, could be potential candidate genes for NAFLD diagnostic and therapeutic options. © 2023 Chutian Wu et al.
引用
收藏
相关论文
共 50 条
  • [1] Identification and validation of cuproptosis-related genes for diagnosis and therapy in nonalcoholic fatty liver disease
    Li, Jinquan
    Zhang, Yi
    Ma, Xiaohan
    Liu, Ruiqi
    Xu, Cuicui
    He, Qin
    Dong, Ming
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025, 480 (01) : 473 - 489
  • [2] Identification and validation of cuproptosis-related molecular clusters in non-alcoholic fatty liver disease
    Liu, Changxu
    Fang, Zhihao
    Yang, Kai
    Ji, Yanchao
    Yu, Xiaoxiao
    Guo, ZiHao
    Dong, Zhichao
    Zhu, Tong
    Liu, Chang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [3] Copper homeostasis and cuproptosis-related genes: Therapeutic perspectives in non-alcoholic fatty liver disease
    Tan, Wangjing
    Zhang, Junli
    Chen, Li
    Wang, Yayuan
    Chen, Rui
    Zhang, Haiming
    Liang, Fengxia
    DIABETES OBESITY & METABOLISM, 2024, 26 (11): : 4830 - 4845
  • [4] Identification and Immune Characteristics of Cuproptosis-Related Genes in Osteoarthritis
    Deng, Hui
    Xiong, Ting
    Yu, Hanxiang
    Li, Mingzhang
    Chen, Zhijun
    Liu, Jun
    Chen, Shenliang
    Tao, Jun
    Xie, Lifeng
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (03): : 1335 - 1351
  • [5] Identification of cuproptosis-related genes in Alzheimer's disease based on bioinformatic analysis
    Ma, Ming-ming
    Zhao, Jing
    Liu, Ling
    Wu, Cai-ying
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [6] Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy
    Lin, Yixuan
    Chen, Kaicong
    Guo, Jinhua
    Chen, Pengxiao
    Qian, Zhi Rong
    Zhang, Tong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 399
  • [7] Identification of cuproptosis-related genes for predicting the development of prostate cancer
    Wang, Xin'an
    Chen, Xi
    Xu, Chengdang
    Zhou, Weidong
    Wu, Denglong
    OPEN MEDICINE, 2023, 18 (01):
  • [8] Identification of the cuproptosis-related hub genes and therapeutic agents for sarcopenia
    Zhu, Yingqian
    Chen, Xin
    Geng, Shasha
    Li, Qingqing
    Li, Yang
    Yuan, Huixiao
    Jiang, Hua
    FRONTIERS IN GENETICS, 2023, 14
  • [9] Identification of key cuproptosis-related genes and their targets in patients with IgAN
    Huagang Lin
    Deping Wu
    Jing Xiao
    BMC Nephrology, 23
  • [10] Identification of key cuproptosis-related genes and their targets in patients with IgAN
    Lin, Huagang
    Wu, Deping
    Xiao, Jing
    BMC NEPHROLOGY, 2022, 23 (01)